1/85
Looks like no tags are added yet.
hallucinogens
class of drugs that produce distortions in perception and alterations in one’s sense of reality
chemically similar to: serotonin, norepinephrine, or acetylcholine
classifications:
serotonin-related
norepinephrine-related
acetylcholine-related
dissociate anesthetics
hallucinogenic
hallucination producing
psychedelic
mind-expanding
pscyhomimetic
having the appearance of psychosis
plant hallucinogens
Psilocybin
DMT
Mescaline
Atropine
Scopolamine
synthetic hallucinogens
LSD
DOM
MDMA
PCP
ketamine
lyseric acid deithlamide
synthetic hallucinogenic drug that alters a person’s perception of reality and of themselves
ergot (found in moldy rye/grains)
lyseric acid (found in ergot→ precursor)
ergot
a fungus found in moldy rye and grains
lysergic acid
highly toxic compound found in ergot; precursor for LSD
LSD history
discovered on accident (1943), Albert Hoffman, a Swiss research chemist was testing new chemical and got trace amounts on fingers
1953: pharmaceutical company wanted to use for schizophrenia research [would just be used for symptom therapy] (resembles symptoms)
MKUltra (1953-1973)
was one of the most heavily experimented drugs with MKUltra
CIA gave people high doses without telling them
prisoners, mental patients, drugs addicts, etc.
director bought entire supply from labs ($4 billion)
tested whether Soviet spies defect against their will if given
1961: Alpert and Leary
Harvard researchers studying hallucinogens
gave this and psilocybin to students
started having session at home and off-campus and got fired
1966- became illegal (state-level)
1970: schedule 1 substance under controlled substances act (federal)
LSD acute effects
doses are extremely potent
typical dose: 5-150 micrograms
oral administration
effects felt within 30-60 minutes
blood levels peak around 2 hours
half life of ~3 hours
very low toxicity: margin of safety 300-600 (one death has ever been reported)
phases of LSD effects
initial effects (30 minutes-2 hours)
psychedelic trip (6-12 hours)
comedown (4-6)
LSD initial effects
1st phase of LSD effects
30 minutes to 2 hours
sympathetic arousal (increased HR, BP, and dilated pupils)
restlessness, euphoria, release of tension, heightened emotions
psychedelic trip
2nd phase of LSD effects
4 main features:
images seen with eyes closed
synesthesia (mixing of senses, sounds as visions)
perception of a multilevel reality
strange and exaggerated configurations of common objects or experiences
good trips vs bad trips are highly variable (what are your expectations, setting you are in, pre-existing conditions
comedown
3rd phase of LSD effects
4-6 hours after
intense mood swings or panic, loss of perception of time, separation between mind and body
LSD on the brain
stimulates 5-HT2a receptors (serotonin)
special subtype of serotonin receptor associated with hallucinogenic effects
5-HT1a linked to depression and anxiety
5-HT2a linked to schizophrenia and psychosis
facts about LSD
does not produce dependence
sometimes produces panic attacks but leads to no long-term psychiatric problems/psychosis
does not increase creativity
does not damage chromosomes
potentially has some long-term residual effects, but unsure (flashbacks)
does not increase violent behavior directly (can make you more impulsive)
serotonin-related hallucinogens
psilocybin
DMT
psilocybin
a serotonin-related hallucinogen drug that originates from a species of mushroom (magic mushrooms)
used as far back as 500 BC
at small doses (4-5mg) causes relaxation
at larger doses (15mg+) causes hallucinations and time distortions
mimics and triggers the release of serotonin
psilocybin vs LSD
less potent (larger doses needed)
shorter trips (4-6 hours total)
more visual effects, less emotionally intense
decreased risk of paranoia
depression and treatment-resistant depression
granted “breakthrough therapy” status by FDA in 2018
patient goes on psilocybin trip in a safe, controlled environment while therapist asks questions
followed up with talk therapy
psilocybin in psychotherapy
PTSD/Trauma
decreases overall symptoms of trauma
creates safer environment for talking about trauma
Anxiety and end-of-life anxiety
generally decreases anxiety symptoms
enhances spiritual wellbeing
substance abuse
alcohol and tobacco
best when combined with psychotherapy
promotes neuroplasticity
breaks up rigid thought patterns
dimethyltryptamine
short acting hallucinogenic drug taken from the bark of trees nativeto Central and South America
“The businessman’s LSD”
similar to LSD but with way shorter effects
most effects over in an hour
norepinephrine-related hallucinogens
mescaline
MDMA
mescaline
hallucinogenic drug derived from the peyote cactus
acts very similarly to LSD (in the sense of adrenaline)
used in religious ceremonies in the Native American church
MDMA
synthetic hallucinogenic drug that has both stimulant and hallucinogenic properties
schedule 1 substance
acts similarly to methamphetamine
“Rave” drug
acute effects:
increased HR, BP, BT, euphoria, heightened senses, decreased inhibition
toxic effects - hyperthermia, cardiovascular effects
chronic effects:
cognitive impairments, emotional difficulties, confusion, anxiety, impulsive control, sleep problems, attention and memory deficits
MDMA potential therapeutic application
PTSD
severe symptoms
comorbid with other disorders
special populations (i.e. veterans)
Recent studies:
67% remission for MDMA + therapy
vs 32% for placebo
71% remission for MDMA + therapy vs 48% for placebo (2023)
vs 48% for placebo (2023)
acetylcholine-related hallucinogens
amanita muscaria (fly agaric)
anticholinergic drugs
atropine
scopolamine
amanita muscaria
hallucinogenic drug derived from a species of mushroom containing the hallucinogen ibotenic acid, which increase the activity of acetylcholine
historically, taken by vikings before battle to give them energy
can be dangerous and result in twitching, spasms, dizziness, and aggression
anticholinergic drugs
drugs that block the parasympathetic effects of acetylcholine (acetylcholine-blocking drugs)
ex: Atropine
ex: scopolamine
atropine
anticholinergic hallucinogenic drug derived from the nightshade plant, used to stabilize heart rate
highly lethal
effects: accelerated heart rate, increased blood pressure, reduced saliva/mucus, possible lightheadedness
scopolamine
anticholinergic hallucinogen drug derived from themandrake plant, used to treat nausea and motion sickness
effects: reduced saliva/mucus production, relaxation of smooth muscles in stomach
dissociative anesthetics
class of drug that causes an out of body trance-like state associated with pain relief, sedation, and amnesia
use usually results in either partial or total amnesia
alters glutamate activity (increases a low doses, decreases at high doses)
ex: PCP and ketamine (and salvia)
salvia divinorium
type of dissociative anesthetic
intense and short acting
phencyclidine
a dissociative anesthetic hallucinogen that produces disorientation, agitation, aggression, analgesia, and amnesia
has stimulant, depressant, and analgesic properties
difficult to regulate, unpredictable effects
schedule 2 substance
effects:
mania, depression, severe anxiety, prolonged stares, sudden mood changes, confusion, paranoia, and unpredictable aggression
makes people able to withstand considerable amounts of pain
hallucinations specifically about one’s own body
partial or total amnesia
deaths from suicides, accidental/intentional mutilations, drownings, falls, etc.
ketamine
a dissociative anesthetic hallucinogen used primarily as an anesthetic for medical procedures
schedule 3 substance
acts very similarly to PCP
effects:
pain relief, increased pain tolerance, sedation, trance-like state
partial or total amnesia
therapeutic application
effective for treatment-resistant depression
works faster than traditional antidepressants
mental illness in US
more than 1 in 5 U.S adults experience
1 in 20 adults have serve mental illnesses
more than 1 in 7 youth have mental health disorder
biomedical model
the perspective that abnormal thoughts and behaviors associated with mental illness are the results of abnormal biochemical processes in the brain
by altering these processes (using drugs) we can address these symptoms
psychiatric drugs
a type of medication used to treat some form of mental illness
antipsychotic drugs
drugs intended to treat the symptoms of schizophrenia
block D2 receptors (dopaminergic receptors)
schizophrenia
severe mental disorder that involves abnormal perceptions of reality; extremely high heritability, occurs in ~1% of the population
symptoms (positive/additive):
hallucinations- visual/auditory stimuli that aren’t really there
delusions- beliefs about oneself or events that aren’t rooted in reality
paranoia- from disordered thinking, can be fear of attacks
disorientations- confusion about present time/place
psychotic history
mid 1950’s- around 50% of hospitalized patients were psychiatric patients
majority were for schizophrenia (overdiagnosed)
barbiturates, lobotomies common
number of mental hospital patients decreased 80% over the next 30 years
1955- introduction of antipsychotic drugs (cut the number of schizophrenia patients in half)
psychiatric patients only admitted to mental hospitals for limited periods of time (deinstitutionalization)
first generation antipsychotics
typical
developed in the 1950’s
ex: chlorpromzine (thorazine), haloperidol (haldol)
significant reduction of hallucinations and delusions
doesn’t affect less severe symptoms (apathy, disorientations)
resulted in Parkinson-like symptoms (tarditive dyskinesia, stiff walk, slow movement, loss of coordination)
FULLY BLOCK D2 RECEPTORS—-PARKINSON’S LIKE SYMPTOMS
second generation antipsychotics
atypical
developed in 1980’s
ex: clozapine (clozaril), risperodone (risperdal), quetiapine (seroquel)
significant reduction of hallucinations and delusions AND less severe symtpoms and NO Parkinson-like symptoms
potential for weight gain, hyperglycemia, diabetes, heart problems, blood disease
PARTIALLY BLOCK D2 RECEPTORS (and some serotonin receptors)
serotonin decreases dopamine production
third-generation antipsychotics
new atypical
developed in 2000’s
ex: aripiprazol (ablify), lumateperone (caplyta)
significant reduction of hallucinations and delusions AND less severe symptoms AND no Parkinson's-like symptoms AND no weight gain or diabetes risk
MODULATES D2 RECEPTORS—only in specific neural pathways
only blocks those in neural pathways with elevated dopamine activity
antidepressant drugs
drugs intended to treat the symptoms of depression
First developed in 1950’s—-discovered on accident, improved mood was a “side effect” of TB treatment
depression is so different from person to person, not one type is the “best”
depression
the most common mood disorder; symptoms include persistent sadness, loss of interest in activities, low energy
around 1 in 5 people will meet criteria during their lifetime
First generation antidepressants
1950’s
include:
monoamine oxidase inhibitors
tricyclic antidepressants
no longer widely prescribed due to adverse side effects
monoamine oxidase inhibitors
type of first generation (MAOIs)
antidepressants that prevent the breakdown of serotonin, dopamine, and norepinephrine
ex: Phenelzine (Nardil), Tranylcypromine (Parnate)
extremely strict dietary restrictions
present in liver, breaks down tyramine
excess tyramine increases stroke risk and BP
tricyclic antidepressants
type of first generation (TCA)
antidepressants that prevent the reuptake of serotonin and norepinephrine
ex: Nortriptylin (Pamelor), Imipramine (Tofranil)
no dietary restrictions, can cause dizziness, dry mouth, HR issues, etc.
second generation antidepressants
type of antidepressants created in 1980
include:
selective serotonin reuptake inhibitors (SSRI)
Serotonin antagonist and reuptake inhibitors (SARI)
most common first-line choice for treatment
selective serotonin reuptake inhibitors
type of second generation antidepressant
antidepressants that prevent the reuptake of serotonin
ex: Escitalopram (Lexapro), Fluoxetine (Prozac), Setraline (Zoloft)
fewer physiological side effects than first gen
serotonin antagonist and reuptake inhibitors
type of second generation antidepressant
antidepressants that prevent the reuptake of serotonin and inhibit a protein that typically inhibits serotonin production
ex: Trazodone (Desyrel), Nefazodone (Serzone)
not widely prescribed for depression, sometimes used for insomnia and panic attacks
third generation antidepresants
type of antidepressant made in 1990
includes: serotonin-norepinephrine reuptake inhibitors (SNRI)
Most recently developed; good alternatives to SSRI
serotonin-norepinephrine reuptake inhibitors
type of 3rd generation antidepressant
type of antidepressant that prevents the reuptake of serotonin and norepinephrine
ex: Duloxetine (Cymbalta(, Venlafaxine (Effexor)
similar mechanism as tricyclics, but with larger margin of safety and fewer rise effects
off-label usage
the use of psychiatric medications for purposes other than what they are specified for
psychiatric disorders may overlap in neurological pathways
drugs can treat multiple disorders
ex: SSRI for anxiety disorders
mood stabilizers
medications used to treat the symptoms of bipolar disorder by reducing the severity of both manic and depressive symptoms
bipolar disorder
disorder characterized by intense mood swings between mania and depression
off label approaches; second gen (atypical) antipsychotics
ex: Risperodone (Risperdal) and Quetiapine (Seroquel)
lithium carbonate
gold standard treatment for bipolar disorder; levels out strong mood swings
Autism Spectrum Disorder
developmental disability that impairs social functioning and produces repetitive patterns of behavior
off label approaches: second gen and third gen antipsychotics
ex: Risperodone (Risperdal) and Aripiprazole (Abilify)
Obsessive Compulsive disorder
mental health condition characterized by uncontrollable recurring thoughts (obsessions) and behaviors (compulsions)
off label approaches: SSRI
fluoxetine (Prozac), Sertraline (Zoloft), etc.
deinstitutionalization history
prior to 1960’s- main approach to treating severely impaired psychiatric patients is institutionalization at large mental hospitals
1960’s- supreme court decides that involuntary admission to large psychiatric hospitals would only be allowed if there were no other feasible means of treatment with more freedom
deinstitutionalization
social policy that involves encouraging the treatment of individuals with mental illness in a community-based program rather than a large mental hospital
good at first, many mental health centers did not live up to expectations
1/3 of the homeless population have depression, bipolar disorder, or schizophrenia
around 350,000 individuals who are in jail or prison have depression, bipolar disorder, or schizophrenia
substance abuse prevention objectives
establishing constructive lifestyles and norms that discourage substance abuse
establishing social and physical environments that facilitate a drug-free lifestyle
supply-side approaches
reduce the supply of drugs in our soiety
law enforcement, drug trafficking control
led by DEA